Gadolinium-based contrast agent (GBCA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gadolinium-based contrast agent (GBCA), covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions [Phase 3]